PL3099305T3 - Sposoby i systemy do określania skutecznego schematu terapeutycznego i odkrywania leku - Google Patents
Sposoby i systemy do określania skutecznego schematu terapeutycznego i odkrywania lekuInfo
- Publication number
- PL3099305T3 PL3099305T3 PL15739850.4T PL15739850T PL3099305T3 PL 3099305 T3 PL3099305 T3 PL 3099305T3 PL 15739850 T PL15739850 T PL 15739850T PL 3099305 T3 PL3099305 T3 PL 3099305T3
- Authority
- PL
- Poland
- Prior art keywords
- determination
- systems
- methods
- drug discovery
- therapeutic regimen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/60—In silico combinatorial chemistry
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/70—Machine learning, data mining or chemometrics
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Computing Systems (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Library & Information Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461932156P | 2014-01-27 | 2014-01-27 | |
| PCT/US2015/013133 WO2015113062A1 (en) | 2014-01-27 | 2015-01-27 | Methods and systems for determination of an effective therapeutic regimen and drug discovery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3099305T3 true PL3099305T3 (pl) | 2026-04-13 |
Family
ID=53678467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15739850.4T PL3099305T3 (pl) | 2014-01-27 | 2015-01-27 | Sposoby i systemy do określania skutecznego schematu terapeutycznego i odkrywania leku |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10093982B2 (pl) |
| EP (1) | EP3099305B1 (pl) |
| ES (1) | ES3062928T3 (pl) |
| PL (1) | PL3099305T3 (pl) |
| WO (1) | WO2015113062A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3055185T3 (en) | 2014-03-28 | 2026-02-10 | Univ Duke | Treatment of an estrogen receptor positive breast cancer using a selective estrogen receptor modulator |
| KR20250152679A (ko) | 2015-04-29 | 2025-10-23 | 래디어스 파마슈티컬스, 인코포레이티드 | 암을 치료하는 방법 |
| CN109272036B (zh) * | 2018-09-14 | 2021-07-02 | 西南交通大学 | 一种基于深度残差网络的随机蕨目标跟踪方法 |
| US11721441B2 (en) | 2019-01-15 | 2023-08-08 | Merative Us L.P. | Determining drug effectiveness ranking for a patient using machine learning |
| US10515715B1 (en) | 2019-06-25 | 2019-12-24 | Colgate-Palmolive Company | Systems and methods for evaluating compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005028624A2 (en) | 2003-09-15 | 2005-03-31 | Plexxikon, Inc. | Molecular scaffolds for kinase ligand development |
| EP1828389B1 (en) | 2004-11-30 | 2011-10-05 | The University Of British Columbia | Sparc promoter mutations associated with drug resistance, and methods associated therewith |
| WO2013056178A2 (en) * | 2011-10-14 | 2013-04-18 | Foundation Medicine, Inc. | Novel estrogen receptor mutations and uses thereof |
-
2015
- 2015-01-27 US US14/606,918 patent/US10093982B2/en active Active
- 2015-01-27 WO PCT/US2015/013133 patent/WO2015113062A1/en not_active Ceased
- 2015-01-27 EP EP15739850.4A patent/EP3099305B1/en active Active
- 2015-01-27 ES ES15739850T patent/ES3062928T3/es active Active
- 2015-01-27 PL PL15739850.4T patent/PL3099305T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3099305A4 (en) | 2017-12-06 |
| WO2015113062A1 (en) | 2015-07-30 |
| US10093982B2 (en) | 2018-10-09 |
| ES3062928T3 (en) | 2026-04-14 |
| US20150211074A1 (en) | 2015-07-30 |
| EP3099305A1 (en) | 2016-12-07 |
| EP3099305B1 (en) | 2025-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273679A (en) | Medical pad systems and methods | |
| IL269462B (en) | mdm2 inhibitors and therapeutic methods using them | |
| IL267241A (en) | System and methods for identifying ransomware | |
| IL252417B (en) | Use of erythrohydroxybupropion to increase plasma drug level | |
| PT3139986T (pt) | Sistema para administração de gás terapêutico | |
| SG11201609966SA (en) | Drug delivery system and method of use | |
| EP3104821A4 (en) | Therapeutic cooling device and system | |
| ZA201701922B (en) | Range finding apparatus and system | |
| SG11201608483PA (en) | Drug delivery systems and related methods of use | |
| GB201715793D0 (en) | Systems and methods for contextual discovery of device functions | |
| IL251477A0 (en) | Anti-ang2 antibodies and methods of use | |
| PL3240777T3 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
| EP3164121A4 (en) | Combination drug therapies for cancer and methods of making and using them | |
| EP3132049A4 (en) | Device and methods of using device for detection of aminoacidopathies | |
| EP3171848A4 (en) | Dose request systems and methods | |
| IL253157A0 (en) | Systems and methods for improving the transfer of molecules that encourage bone growth for bone restoration | |
| ZA201802134B (en) | Therapeutic compounds and methods of use thereof | |
| PL3099305T3 (pl) | Sposoby i systemy do określania skutecznego schematu terapeutycznego i odkrywania leku | |
| IL250146A0 (en) | Methods for determining drug response of patient-specific mutations | |
| GB201416792D0 (en) | Methods and systems of handling patent cliams | |
| GB2537569B (en) | Location detecting system and location detecting method of the location detecting system | |
| GB201409603D0 (en) | An inhalable medicament | |
| EP3282932A4 (en) | Methods and system for assessment of peripheral perfusion | |
| GB201412551D0 (en) | Portable method for the detection of drugs |